Anti-coreceptor therapy drives selective T cell egress by suppressing inflammation-dependent chemotactic cues.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  JCI Insight

• Publication date

  2016-10-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/jci.insight.87636PMID 27777971PMCID PMC5070954
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-CD3/Anti-CXCL10 Antibody Combination Therapy Induces a Persistent Remission of Type 1 Diabetes in Two Mouse Models

  2015cited by this paper
• Functional Redundancy of CXCR3/CXCL10 Signaling in the Recruitment of Diabetogenic Cytotoxic T Lymphocytes to Pancreatic Islets in a Virally Induced Autoimmune Diabetes Model

  2013cited by this paper
• Defining the Transcriptional and Cellular Landscape of Type 1 Diabetes in the NOD Mouse

  2013cited by this paper
• β-Cell–Specific IL-2 Therapy Increases Islet Foxp3+Treg and Suppresses Type 1 Diabetes in NOD Mice

  2013cited by this paper
• Long-Term Remission of Diabetes in NOD Mice Is Induced by Nondepleting Anti-CD4 and Anti-CD8 Antibodies

  2012cited by this paper
• Targeting the chemokine receptor system.

  2012cited by this paper
• T Cell Apoptosis and Induction of Foxp3+ Regulatory T Cells Underlie the Therapeutic Efficacy of CD4 Blockade in Experimental Autoimmune Encephalomyelitis

  2012cited by this paper
• Targeting chemokines and chemokine receptors with antibodies.

  2012cited by this paper
• Expression and Regulation of Chemokines in Murine and Human Type 1 Diabetes

  2012cited by this paper
• Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans

  2011cited by this paper
• Entry of diabetogenic T cells into islets induces changes that lead to amplification of the cellular response

  2011cited by this paper
• Therapeutic antibodies directed at G protein-coupled receptors

  2010cited by this paper
• Cyclosporin and methotrexate therapy induces remission in type 1 diabetes mellitus

  2010cited by this paper
• CD8+ T cells specific for β cells encounter their cognate antigens in the islets of NOD mice

  2009cited by this paper
• Human peripheral blood leucocyte non‐obese diabetic‐severe combined immunodeficiency interleukin‐2 receptor gamma chain gene mouse model of xenogeneic graft‐versus‐host‐like disease and the role of host major histocompatibility complex

  2009cited by this paper
• T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event.

  2009cited by this paper
• Type 1 diabetes development requires both CD4+ and CD8+ T cells and can be reversed by non-depleting antibodies targeting both T cell populations.

  2009cited by this paper
• Enterovirus Infection, CXC Chemokine Ligand 10 (CXCL10), and CXCR3 Circuit

  2009cited by this paper
• Human Immunodeficiency Virus Type 1 gp120 Reprogramming of CD4+ T-Cell Migration Provides a Mechanism for Lymphadenopathy

  2009cited by this paper
• Tailoring T-cell receptor signals by proximal negative feedback mechanisms

  2008cited by this paper
• IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes.

  2008cited by this paper
• Reprogramming the immune system: co‐receptor blockade as a paradigm for harnessing tolerance mechanisms

  2008cited by this paper
• IFN-γ-Dependent Regulatory Circuits in Immune Inflammation Highlighted in Diabetes1

  2008cited by this paper
• Isotype selection in antibody engineering

  2007cited by this paper
• Role of chemokines in endocrine autoimmune diseases.

  2007cited by this paper
• Production of Monoclonal Antibodies

  2006cited by this paper
• Autoimmune Destruction of Pancreatic β Cells

  2005cited by this paper
• The NOD mouse: a model of immune dysregulation.

  2005cited by this paper
• Islet-Specific Expression of CXCL10 Causes Spontaneous Islet Infiltration and Accelerates Diabetes Development1

  2005cited by this paper
• Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities.

  2005cited by this paper
• Altered Proximal T‐Cell Receptor Signalling Events in Mouse CD4+ T Cells in the Presence of Anti‐CD4 Monoclonal Antibodies: Evidence for Reduced Phosphorylation of Zap‐70 and LAT

  2003cited by this paper
• Perturbation of naive TCR transgenic T cell functional responses and upstream activation events by anti‐CD4 monoclonal antibodies

  2002cited by this paper
• Pancreatic Lymph Nodes Are Required for Priming of β Cell Reactive T Cells in NOD Mice

  2002cited by this paper
• β cells are responsible for CXCR3-mediated T-cell infiltration in insulitis

  2002cited by this paper
• IFN-γ Affects Homing of Diabetogenic T Cells1

  2001cited by this paper
• Nondepleting Anti-CD4 Has an Immediate Action on Diabetogenic Effector Cells, Halting Their Destruction of Pancreatic β Cells1

  2000cited by this paper
• Absolute requirement of macrophages for the development and activation of beta-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice.

  1999cited by this paper
• Ability of a nondepleting anti-CD4 antibody to inhibit Th2 responses and allergic lung inflammation is independent of coreceptor function.

  1999cited by this paper
• CD4-mediated signals induce T cell dysfunction in vivo.

  1999cited by this paper
• Production of Monoclonal Antibodies

  1999cited by this paper
• Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse.

  1998cited by this paper
• Thymus‐dependent monoclonal antibody‐induced protection from transferred diabetes

  1998cited by this paper
• Autoimmunity and type I diabetes.

  1997cited by this paper
• The Efficiency of CD4 Recruitment to Ligand-engaged TCR Controls the Agonist/Partial Agonist Properties of Peptide–MHC Molecule Ligands

  1997cited by this paper
• Insulin-Dependent Diabetes Mellitus Review

  1996cited by this paper
• Insulin-dependent diabetes mellitus.

  1996cited by this paper
• The role of CD8+ T cells in the initiation of insulin‐dependent diabetes mellitus

  1996cited by this paper
• Localization of the gene for the human MIG cytokine on chromosome 4q21 adjacent to INP10 reveals a chemokine "mini-cluster".

  1996cited by this paper
• The mechanism of action of cyclosporin A and FK506.

  1996cited by this paper
• Control of immune-mediated disease of the central nervous system with monoclonal (CD4-specific) antibodies.

  1993cited by this paper
• Extensive CD4 cross-linking inhibits T cell activation by anti-receptor antibody but not by antigen.

  1992cited by this paper
• The use of a non‐depleting anti‐CD4 monoclonal antibody to re‐establish tolerance to β cells in NOD mice

  1992cited by this paper
• Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma.

  1991cited by this paper
• Cross-linking of T-cell surface molecules CD4 and CD8 stimulates phosphorylation of the lck tyrosine protein kinase at the autophosphorylation site

  1990cited by this paper
• Role of CD4 in thymocyte selection and maturation

  1989cited by this paper
• Evidence for Initial Involvement of Macrophage in Development of Insulitis in NOD Mice

  1988cited by this paper
• The influence of valence on the functional activities of monoclonal anti-L3T4 antibodies. Discrimination of signaling from other effects.

  1987cited by this paper
• Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus.

  1985cited by this paper
• γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins

  1985cited by this paper
• Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset.

  1984cited by this paper

• Induction of Antigen-Specific Tolerance in a Multiple Sclerosis Model without Broad Immunosuppression.

  2025cites this paper
• The Role of T Cell Receptor Signaling in the Development of Type 1 Diabetes

  2021cites this paper
• Evolving Antibody Therapies for the Treatment of Type 1 Diabetes

  2021cites this paper
• Coreceptor therapy has distinct short- and long-term tolerogenic effects intrinsic to autoreactive effector T cells

  2021cites this paper
• Anti-CD8 monoclonal antibody-mediated depletion alters the phenotype and behavior of surviving CD8+ T cells

  2019cites this paper
• Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes

  2018cites this paper
• Type 1 Diabetes: A Chronic Anti-Self-Inflammatory Response

  2017cites this paper